How a Defective Brain Transport Protein Can Lead to Severe Epilepsy
Researchers have uncovered how mutations in the SLC13A5 transporter impair citrate uptake in neurons, leading to severe epilepsy and developmental delays. This study advances understanding of genetic causes of neurological disorders and paves the way for targeted treatments.
Recent research has shed light on how mutations in a specific brain transport protein, SLC13A5, can cause a severe form of epilepsy known as developmental epileptic encephalopathy (DEE). Citrate, a crucial molecule in neuronal metabolism and function, relies on this transporter for proper cellular uptake. When SLC13A5 malfunctions due to genetic mutations, citrate transport is impaired, disrupting neuronal activity and development.
Building upon data from the RESOLUTE and REsolution projects, scientists at CeMM have conducted a comprehensive study of the structure and function of SLC13A5, analyzing nearly 10,000 genetic mutations through advanced deep mutational scanning techniques. From this vast dataset, 38 mutant variants were selected for detailed experimental analysis, revealing various molecular mechanisms by which these mutations influence transporter production, localization, and citrate transport efficiency.
The findings demonstrate that different mutations affect SLC13A5's stability and behavior within cells, contributing to the disease pathology. Identifying and characterizing these disease-causing variants significantly advances our understanding of how genetic mutations lead to neurological disorders such as epilepsy.
Citrate’s role in neuronal function is vital, as it influences neuronal signaling and brain metabolism. The disruption of citrate transport due to faulty SLC13A5 protein impairs neural development and function, resulting in severe epileptic symptoms and developmental delays. These insights open new avenues for targeted therapeutic strategies aimed at correcting or compensating for these genetic defects, potentially improving outcomes for affected individuals.
The research highlights the importance of systematic genetic variant investigation, especially in rare diseases. By understanding the molecular effects of specific mutations, scientists can better grasp disease mechanisms and develop precise interventions.
Source: https://medicalxpress.com/news/2025-06-faulty-protein-brain-trigger-severe.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Blood Test Detects HPV-Related Head and Neck Cancers Up to a Decade Before Symptoms Appear
A new blood test, HPV-DeepSeek, can identify HPV-associated head and neck cancers up to 10 years before symptoms appear, promising early detection and improved outcomes.
Understanding the Rise of DNA Testing by Australian Health Insurers
Australian health insurers are now providing DNA tests to predict individual responses to medications, raising important questions about data security, ethical use, and future health screening. Learn what you need to know about this emerging trend.
Major Advances in Psychiatric Genomics Over the Last Five Years
Recent discoveries in psychiatric genomics have transformed our understanding of the genetic basis of mental health disorders, revealing new pathways, shared genetic factors, and future directions for personalized treatment.
Nuclear Migration in T Cells Enhances Infection Defense
New research uncovers how the migration of the T cell nucleus enhances immune responses by positioning to the immune synapse, enabling rapid production of molecular weapons against infections and cancer.